ArticleAnaerobe2025
CAT-GxD: Centralized access to gene expression datasets.
Article in Anaerobe, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
objectivesExtensive multi-omic bacterial gene expression datasets are publicly available, but tools that unify these datasets for interpretation and hypothesis-testing are limited. The complexity and requirement of specialized bioinformatics and programming expertise pose significant major barriers for researchers attempting to query and analyze these datasets. Our objective was to develop an integrated search engine that simplifies access to publicly available gene expression data to facilitate comparison and analysis of multi-omics datasets.
methodsWe developed the Centralized Access to Gene Expression Datasets (CAT-GxD) search engine to provide integrated access to, and facilitate analysis of, publicly available transcriptomics and proteomics datasets of the CDC Urgent Threat pathogen Clostridioides difficile. Manual data curation was performed to integrate and standardize all 74 nonredundant transcriptomics and quantitative proteomics datasets available at Gene Expression Omnibus (GEO) database and ProteomeXchange Consortium. The CAT-GxD search engine, developed on open-source R-shiny framework, is available at https://viz.datascience.arizona.edu/catgxd/.
resultsCAT-GxD successfully consolidated disparate transcriptomics and proteomics datasets, supporting interpretation and hypothesis testing. CAT-GxD provides customizable visualization of gene expression data under different conditions. We demonstrate the utility of CAT-GxD in analyzing the contribution of RNA polymerase, nitrogen-limitation N (RpoN) to C. difficile biology, and highlight the RpoN-dependent regulation of genes treated with succinate and the secondary bile acid deoxycholate.
conclusionsCAT-GxD streamlines the analysis of C. difficile multi-omic data, reducing the complexity and analysis time. It facilitates the generation of novel hypotheses and the identification of anti-infective targets, and can be adapted to incorporate data analysis paradigms for diverse organisms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.